|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.04.26 - 18:30
|
Formpipe Software publishes its 2025 Annual Report (Cision)
|
|
|
Formpipe Software publishes its Annual Report for the financial year 2025 on the company's website today.
As previously communicated, the company intends to change its name to Lasernet Group, subject to approval at the upcoming Annual General Meeting.
The The Annual Report in Swedish is available at the company's website https://ir.formpipe.com/reports-and-presentations where it can be downloaded as PDF and in European Single Electronic Format (ESEF).
An English translation of the report will be available at the website from the middle of May....
|
|
|
03.04.26 - 18:18
|
Availability of ICAPE Group′s Full Year 2025 Financial Report (Business Wire)
|
|
|
FONTENAY-AUX-ROSES, France--(BUSINESS WIRE)--Regulatory News:
The ICAPE Group (ISIN code: FR001400A3Q3 – ticker: ALICA), a global technology distributor of printed circuit boards (“PCBs”) and custom electronic parts, announces the availability of its 2025 financial report.
ICAPE announces the availability of its Annual Financial Report as of December 31, 2025, in accordance with applicable regulations.
This document was filed with the French Financial Markets Authority (AMF) on April 3, 2026, in PDF format and in French. The English version will be available later this month.
It can be viewed or downloaded in French on the Company's website: www.icape-group.com (Documentation - ICAPE Group).
It is also available on the AMF website: https://www.amf-france.org/fr.
The 2025 Annual Financial Report includes, in particular:
The management report
The description of the Group's share repurchase program
The corporate governance report
The Group's consolidated financial statements
The company's annual fi...
|
|
|
03.04.26 - 18:12
|
Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts (24/7 Wall St.)
|
|
|
One of the world's leading healthcare names, Novo Nordisk (NYSE:NVO) cut prices on Wegovy and Ozempic by up to 48% in India at the start of April 2026, a direct response to low-cost generic semaglutide flooding the market. A debate has been building on Reddit for weeks: is Novo Nordisk a deeply undervalued pharmaceutical franchise ... Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts...
|
|
|
|
|
|
|
|
|
03.04.26 - 18:06
|
Legrand: Total Number of Shares and Voting Rights (Business Wire)
|
|
|
LIMOGES, France--(BUSINESS WIRE)--Regulatory News:
Legrand (Paris:LR):
Date
Total number of shares composing the share capital
Total number of voting rights
March 31, 2026
262,245,733
Theoretical number of voting rights:
262,245,733
Number of exercisable voting rights*:
261,364,529
(*) After deduction of shares without voting rights
The variation of the total number of shares since the latest release of financial statements is reminded below:
Total number of shares as at January 31, 2026
262,245,733
Exercise of stock options
0
Total number of shares as at February 28, 2026
262,245,733
Exercise of stock options
0
Total number of shares as at March 31, 2026
262,245,733
Exercise of stock options
0
Key financial dates
2026 first-quarter results: May 7, 2026
“Quiet period1” starts : April 7, 2026
General Meeting of Shareholders : May 27, 2026
Ex-dividend date : May 29, 2026
Dividend payment : June 2, 2026
2026 first-half results : July 29, 2026
“Quiet period1” starts : June 29, 2026
ABOUT LEGRAND...
|
|
Alle News zu Europa 5694.8665 0.0% (E.St.50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
